Researchers at Freedom Meditech are developing devices that can non-invasively scan the eye to monitor glucose levels in people with diabetes.
The devices are based optical polarimetry, a technique that measures the concentration of glucose in the aqueous humour, one of the fluids in the eye.
The company has successfully completed a study involving rabbit models, in which the optical polarimetry technique was used to non-invasively measure glucose levels.
Freedom Meditech chairman and CEO Craig Misrach said the company is pleased with the promising results of the study and is planning to move the research to the next phase of human clinical studies.
“We believe that our proprietary technology could someday become a standard of care for quick and convenient glucose monitoring for people with diabetes,” Misrach said.